The official line with CSIRO is they were "selected" Not sure if Recce submitted their candidate for consideration.
The good news is despite all this viral side show we have our original focus to look forward to:
1. Sepsis phase 1 clinical trial
2. Burns topical phase 1 clinical trial.
Obviously the two above trials are further advanced than the viral studies. The viral research is no where near being injected into humans but it is obviously a huge market. Its good the trials are commencing shortly for the above!
Dont forget H. pylori too another huge indication. So many Christmas presents to look forward too!
RCE Price at posting:
$1.10 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)